Adam D. Swick

718 total citations
23 papers, 506 citations indexed

About

Adam D. Swick is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Adam D. Swick has authored 23 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Adam D. Swick's work include Head and Neck Cancer Studies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Adam D. Swick is often cited by papers focused on Head and Neck Cancer Studies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Adam D. Swick collaborates with scholars based in United States, Netherlands and New Zealand. Adam D. Swick's co-authors include Randall J. Kimple, Paul F. Lambert, Andrew P. Stein, Sandeep Saha, Menggang Yu, John Yin, Yong Pan, Grace Spatafora, Andrea C. Timm and Jay W. Warrick and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Adam D. Swick

23 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam D. Swick United States 13 176 175 119 96 84 23 506
Janny Dijkstra Netherlands 4 133 0.8× 129 0.7× 170 1.4× 37 0.4× 43 0.5× 4 413
Mercedes Porosnicu United States 17 276 1.6× 287 1.6× 174 1.5× 204 2.1× 132 1.6× 50 1.0k
Clorinda Annunziata Italy 12 147 0.8× 286 1.6× 100 0.8× 186 1.9× 68 0.8× 16 647
Monique G.C.T. van Oijen Netherlands 11 155 0.9× 178 1.0× 82 0.7× 48 0.5× 51 0.6× 11 543
K. Syrj�nen Finland 14 269 1.5× 98 0.6× 87 0.7× 383 4.0× 34 0.4× 20 705
Wichai Pornthanakasem Thailand 14 289 1.6× 353 2.0× 128 1.1× 123 1.3× 33 0.4× 19 812
Farhad Ghasemi Canada 15 208 1.2× 201 1.1× 94 0.8× 61 0.6× 59 0.7× 29 584
Siribang-on Piboonniyom United States 7 287 1.6× 320 1.8× 38 0.3× 254 2.6× 18 0.2× 7 696
Cláudio Osmar Pereira Alexandre Brazil 12 227 1.3× 123 0.7× 34 0.3× 269 2.8× 19 0.2× 24 541

Countries citing papers authored by Adam D. Swick

Since Specialization
Citations

This map shows the geographic impact of Adam D. Swick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam D. Swick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam D. Swick more than expected).

Fields of papers citing papers by Adam D. Swick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam D. Swick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam D. Swick. The network helps show where Adam D. Swick may publish in the future.

Co-authorship network of co-authors of Adam D. Swick

This figure shows the co-authorship network connecting the top 25 collaborators of Adam D. Swick. A scholar is included among the top collaborators of Adam D. Swick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam D. Swick. Adam D. Swick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swick, Adam D., et al.. (2022). Abstract 3003: The effects of autophagy inhibition on HNSCC sensitivity to CTX. Cancer Research. 82(12_Supplement). 3003–3003. 1 indexed citations
2.
Ayuso, José M., Adam D. Swick, Melissa C. Skala, et al.. (2019). Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cells. Scientific Reports. 9(1). 12480–12480. 32 indexed citations
3.
Iida, Mari, Kwangok P. Nickel, Adam D. Swick, et al.. (2019). Abstract A128: AXL mediates cetuximab resistance through tyrosine 821 and activation of c-Abl kinase in head and neck cancer. Molecular Cancer Therapeutics. 18(12_Supplement). A128–A128. 1 indexed citations
4.
SenthilKumar, Gopika, et al.. (2018). Abstract 1344: Autophagy contributes to therapeutic resistance in head and neck cancer. Cancer Research. 78(13_Supplement). 1344–1344. 1 indexed citations
5.
Swick, Adam D., et al.. (2018). Identity Crisis – Rigor and Reproducibility in Human Cell Lines. Radiation Research. 189(6). 551–552. 1 indexed citations
6.
Swick, Adam D., Michael M. Fisher, Emmanuel Sampene, et al.. (2017). Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC. Molecular Cancer Therapeutics. 16(7). 1257–1268. 28 indexed citations
7.
Swick, Adam D., Lauryn R. Werner, Kwangok P. Nickel, et al.. (2017). Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition. Clinical Cancer Research. 23(20). 6044–6053. 21 indexed citations
8.
Voigt, Emily A., Adam D. Swick, & John Yin. (2016). Rapid induction and persistence of paracrine-induced cellular antiviral states arrest viral infection spread in A549 cells. Virology. 496. 59–66. 20 indexed citations
9.
Swick, Adam D., Andrew P. Stein, Timothy M. McCulloch, et al.. (2016). Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts. Oral Oncology. 64. 65–72. 22 indexed citations
10.
Iida, Mari, Harsh Bahrar, Toni M. Brand, et al.. (2016). Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab. Molecular Cancer Therapeutics. 15(9). 2175–2186. 33 indexed citations
11.
Fisher, Michael, Adam D. Swick, Kwangok P. Nickel, & Randall J. Kimple. (2016). Selection of Radiosensitizers Based on HRAS Mutation in Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E568–E569. 1 indexed citations
12.
Warrick, Jay W., Andrea C. Timm, Adam D. Swick, & John Yin. (2016). Tools for Single-Cell Kinetic Analysis of Virus-Host Interactions. PLoS ONE. 11(1). e0145081–e0145081. 33 indexed citations
13.
Swick, Adam D., et al.. (2016). Abstract 2129: Induction of autophagy as a mechanism of therapeutic resistance in head and neck cancer. Cancer Research. 76(14_Supplement). 2129–2129. 1 indexed citations
14.
Iida, Mari, Harsh Bahrar, Toni M. Brand, et al.. (2016). Targeting the HER family with Pan-HER effectively overcomes resistance to cetuximab. European Journal of Cancer. 69. S73–S73. 1 indexed citations
15.
Francis, David M., Shyhmin Huang, Eric A. Armstrong, et al.. (2015). Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models. Clinical Cancer Research. 22(3). 633–643. 22 indexed citations
16.
Pesko, Kendra, Emily A. Voigt, Adam D. Swick, et al.. (2015). Genome rearrangement affects RNA virus adaptability on prostate cancer cells. Frontiers in Genetics. 6. 121–121. 6 indexed citations
17.
Stein, Andrew P., Sandeep Saha, Adam D. Swick, et al.. (2015). Prevalence of Human Papillomavirus in Oropharyngeal Cancer. The Cancer Journal. 21(3). 138–146. 162 indexed citations
18.
Swick, Adam D., et al.. (2015). Modulation of therapeutic sensitivity by human papillomavirus. Radiotherapy and Oncology. 116(3). 342–345. 13 indexed citations
19.
Stein, Andrew P., Adam D. Swick, Molly A. Smith, et al.. (2015). Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies. Cancer Medicine. 4(5). 699–712. 18 indexed citations
20.
Swick, Adam D., et al.. (2006). The SloR/Dlg Metalloregulator ModulatesStreptococcus mutansVirulence Gene Expression. Journal of Bacteriology. 188(14). 5033–5044. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026